IRAK4-IN-4
CAS No. 1850276-58-2
IRAK4-IN-4( —— )
Catalog No. M22690 CAS No. 1850276-58-2
IRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 155 | In Stock |
|
| 5MG | 141 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 377 | In Stock |
|
| 50MG | 554 | In Stock |
|
| 100MG | 798 | In Stock |
|
| 200MG | 1070 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIRAK4-IN-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionIRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.
-
DescriptionIRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIRAK4|cGAS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1850276-58-2
-
Formula Weight340.37
-
Molecular FormulaC22H16N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:24 mg/mL(70.51 mM)
-
SMILESCc1ccn2c(C(=O)C(=O)c3ccccc3)c(nc2c1)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.One class has the naphthalene second dione compounds and its derivative of protease modification activities. CN107163044A.
molnova catalog
related products
-
Micromelin
Micromelin is a coumarin from Micromelum minutum (Forst. f.) Seem (family Rutaceae).
-
Tetrahydropalmatine ...
Tetrahydropalmatine (THP) is an alkaloid found in several different plant species, mainly in the Corydalis genus (Yan Hu Suo), but also in other plants such as Stephania rotunda.
-
Rhamnazin
Rhamnazin is an orally active inhibitor of VEGFR2 signaling with an IC50 of 4.68 μM against VEGFR2 kinase. Rhamnazin shows potent antiangiogenic activity and antitumor efficacy. Rhamnazin shows antioxidant and anti-inflammatory properties.
Cart
sales@molnova.com